DD Weisenburger
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment 27
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research 11
- Mesenchymal stem cell research 3
- Hematology top 1%
- Hematopoietic Stem Cell Transplantation 6
- Oncology top 2%
- Viral-associated cancers and disorders 9
- Neurology top 5%
- CNS Lymphoma Diagnosis and Treatment 4
-
- Lung Cancer Treatments and Mutations 5
-
- T-cell and Retrovirus Studies 3
- Co-authors
- Jamés O. ArmitageJ R AndersonAnne KessingerWC ChanJO ArmitageJ. O. ArmitageWG SangerJR Anderson
- Partner nations
- United StatesFranceSweden
In The Last Decade
DD Weisenburger
37 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 93
- Pathology and Forensic Medicine 2.1k
- Genetics 1.0k
- Hematology 697
- Oncology 1.5k
- Neurology 381
Countries citing papers authored by DD Weisenburger
This map shows the geographic impact of DD Weisenburger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by DD Weisenburger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites DD Weisenburger more than expected).
Fields of papers citing papers by DD Weisenburger
This network shows the impact of papers produced by DD Weisenburger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by DD Weisenburger. The network helps show where DD Weisenburger may publish in the future.
Co-authorship network
The 25 scholars most cited alongside DD Weisenburger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 22 | |
| 2 | 2000 | 87 | |
| 3 | 1998 | 58 | |
| 4 | 1998 | 10 | |
| 5 | Epidemiology of the non-Hodgkin’s lymphomas: Distributions of the major subtypes differ by geographic locationsbreakdown → | 1998 | 507 |
| 6 | 1997 | 2 | |
| 7 | 1996 | 103 | |
| 8 | 1995 | 65 | |
| 9 | 1995 | 46 | |
| 10 | 1995 | 64 | |
| 11 | 1995 | 122 | |
| 12 | 1992 | 19 | |
| 13 | 1992 | 99 | |
| 14 | Non-Hodgkin's lymphomas of primary follicle/mantle zone origin. | 1991 | 8 |
| 15 | 1991 | 7 | |
| 16 | 1990 | 80 | |
| 17 | 1990 | 8 | |
| 18 | Allogeneic transplantation of blood-derived, T cell-depleted hemopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia. | 1989 | 112 |
| 19 | 1988 | 14 | |
| 20 | Early leukemic recurrence of non-Hodgkin lymphoma after high-dose anti-neoplastic therapy with autologous marrow rescue. | 1987 | 14 |
About DD Weisenburger
DD Weisenburger is a scholar working on Pathology and Forensic Medicine, Genetics and Hematology, having authored 37 papers that have together received 2.9k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (27 papers), Chronic Lymphocytic Leukemia Research (11 papers), Viral-associated cancers and disorders (9 papers), Hematopoietic Stem Cell Transplantation (6 papers), Lung Cancer Treatments and Mutations (5 papers), CNS Lymphoma Diagnosis and Treatment (4 papers), T-cell and Retrovirus Studies (3 papers) and Mesenchymal stem cell research (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (2.1k citations), Genetics (1.0k citations) and Hematology (697 citations). DD Weisenburger has collaborated with scholars based in United States, France and Sweden. Frequent co-authors include Jamés O. Armitage, J R Anderson, Anne Kessinger, WC Chan, JO Armitage, J. O. Armitage, WG Sanger, JR Anderson, James D. Landmark and Philip J. Bierman. Their work appears in journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.